• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Chorea Companies

    ID: MRFR/HC/3782-HCR
    85 Pages
    Rahul Gotadki
    October 2025

    Companies involved in the field of healthcare, biotechnology, or pharmaceuticals, working on treatments or research related to chorea or neurological disorders.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Chorea Market Research Report - Global Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Chorea Market

    Chorea Key Companies

     

    Latest Chorea Companies Update


    Roche Announced positive Phase 2a trial results for its gene therapy candidate RG6042 for Huntington's disease, paving the way for further development.


    UniQure Received FDA Fast Track designation for its gene therapy candidate AMT-130 for Huntington's disease, accelerating the potential pathway to market.


    Medtronic Launched its new Percept PC+ DBS system with advanced features for more precise targeting and stimulation control in chorea patients.


    Akili Interactive Labs Collaborated with the CHDI Foundation to develop a digital therapeutic game for monitoring motor function in Huntington's disease patients.


    List of Chorea Key Companies in the Market



    • Medtronic plc.

    • Boston Scientific Corporation

    • ALEVA NEUROTHERAPEUTICS SA

    • Pfizer Inc.

    • GlaxoSmithKline plc.

    • Bausch Health Companies Inc.

    • Teva Pharmaceutical Industries Ltd.

    • LivaNova PLC

    • Lundbeck A/S

    • Ipsen

    • Alnylam Pharmaceuticals Inc.

    • RespireRx Pharmaceuticals Inc.

    • Vertex Pharmaceuticals Inc.

    • Prana Biotechnology Ltd.

    • and SOM Innovation Biotech